Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI PET/CT in Ovarian Cancer Staging
2023-505938-98-00Phase 2Completed
- Sponsor
- Aalborg University Hospital
- Start
- Sep 2023
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 68Ga FAPI-46 in ovarian cancer, sponsored by Aalborg University Hospital. Started Sep 2023; status: completed.
02
Drugs
68Ga FAPI-46
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2023-505938-98-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505938-98-00.